PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Texas Instruments Incorporated (TXN)
205.980.01 (0.00%)
205.24 - 207.41
139.95 - 221.69
4.54M / 6.54M (Avg.)
37.59 | 5.48
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-2.92%
Both firms have declining sales. Martin Whitman would suspect an industry slump or new disruptive entrants.
-2.87%
Both firms have negative gross profit growth. Martin Whitman would question the sector’s viability or cyclical slump.
-1.68%
Negative EBIT growth while QRVO is at 810.08%. Joel Greenblatt would demand a turnaround plan focusing on core profitability.
-1.68%
Negative operating income growth while QRVO is at 6.61%. Joel Greenblatt would press for urgent turnaround measures.
-2.71%
Both companies face declining net income. Martin Whitman would suspect external pressures or flawed business models in the space.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-3.18%
Both firms reduce share counts. Martin Whitman would compare buyback intensity relative to free cash flow generation.
-3.45%
Both reduce diluted shares. Martin Whitman would review each firm’s ability to continue repurchases and manage option issuance.
25.02%
Dividend growth of 25.02% while QRVO is flat. Bruce Berkowitz would see if this can become a bigger advantage long term.
-7.05%
Both companies show negative OCF growth. Martin Whitman would analyze broader economic or industry conditions limiting cash flow.
-9.93%
Both companies show negative FCF growth. Martin Whitman would consider an industry-wide capital spending surge or margin compression.
66.42%
10Y revenue/share CAGR at 50-75% of QRVO's 95.48%. Martin Whitman would question if the firm’s offerings lag behind the competitor.
96.86%
5Y revenue/share CAGR above 1.5x QRVO's 27.97%. David Dodd would look for consistent product or market expansions fueling outperformance.
41.72%
Positive 3Y CAGR while QRVO is negative. John Neff might view this as a sharp short-term edge or successful pivot strategy.
241.13%
10Y OCF/share CAGR above 1.5x QRVO's 108.03%. David Dodd would check if a superior product mix or cost edge drives this outperformance.
127.23%
5Y OCF/share CAGR above 1.5x QRVO's 5.08%. David Dodd would confirm if the firm has better cost structures or brand premium boosting mid-term cash flow.
37.02%
Positive 3Y OCF/share CAGR while QRVO is negative. John Neff might see a big short-term edge in operational efficiency.
401.02%
Below 50% of QRVO's 1921.69%. Michael Burry would worry about a sizable gap in long-term profitability gains vs. the competitor.
252.29%
Positive 5Y CAGR while QRVO is negative. John Neff might view this as a strong mid-term relative advantage.
93.61%
Positive short-term CAGR while QRVO is negative. John Neff would see a clear advantage in near-term profit trajectory.
91.65%
Positive growth while QRVO is negative. John Neff might see a strong advantage in steadily compounding net worth over a decade.
10.40%
Positive 5Y equity/share CAGR while QRVO is negative. John Neff might see a clear edge in retaining earnings or managing capital better.
-4.05%
Both show negative short-term equity/share CAGR. Martin Whitman suspects an industry slump or unprofitable expansions for both players.
361.20%
Dividend/share CAGR of 361.20% while QRVO is zero. Bruce Berkowitz sees a slight advantage in stepping up payouts steadily.
355.42%
Stable or rising mid-term dividends while QRVO is cutting. John Neff sees an edge in consistent payouts vs. the competitor.
294.10%
3Y dividend/share CAGR of 294.10% while QRVO is zero. Bruce Berkowitz sees a minor positive difference that could attract dividend-focused investors.
-13.89%
Both reduce receivables yoy. Martin Whitman suspects a shift in the entire niche’s credit approach or softer demand.
-2.21%
Both reduce inventory yoy. Martin Whitman suspects a broader move to lean operations or industry slowdown in demand.
-7.70%
Negative asset growth while QRVO invests at 1.09%. Joel Greenblatt checks if the competitor might capture more market share unless our returns remain higher.
-7.50%
We have a declining book value while QRVO shows 3.14%. Joel Greenblatt sees a fundamental disadvantage in net worth creation vs. the competitor.
No Data
No Data available this quarter, please select a different quarter.
-6.09%
Both reduce R&D yoy. Martin Whitman sees an industry shifting to cost reduction or limited breakthroughs in the near term.
-1.63%
We cut SG&A while QRVO invests at 19.11%. Joel Greenblatt sees a short-term margin benefit but wonders if the competitor invests for future gains.